Nanoformulation of Talazoparib Delays Tumor Progression and Ascites Formation in a Late Stage Cancer Model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanoformulation of Talazoparib Delays Tumor Progression and Ascites Formation in a Late Stage Cancer Model

Published:2019-05-10 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Baldwin Paige,Ohman Anders W.,Medina Jamie E.,McCarthy Eric T.,Dinulescu Daniela M.,Sridhar Srinivas

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference47 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin.,2017

2. Cancer Stat Facts: Ovarian Cancer

3. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer;Bowtell;Nat Rev Cancer.,2015

4. Cancer Stat Facts: Ovarian Cancer;SEER 18 2007–2013.

5. Targeting multidrug resistance in cancer;Szakács;Nat Rev Drug Discov.,2006

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intraperitoneal administration of doxorubicin-encapsulated Brucea javanica oil nanoemulsion against malignant ascites;European Journal of Pharmaceutics and Biopharmaceutics;2024-09

2. PpIX‐enabled fluorescence‐based detection and photodynamic priming of platinum‐resistant ovarian cancer cells under fluid shear stress;Photochemistry and Photobiology;2024-08-27

3. A nano-cocktail of the PARP inhibitor talazoparib and CDK inhibitor dinaciclib for the treatment of triple negative breast cancer;Cancer Nanotechnology;2024-03-23

4. In Situ Formation of Fibronectin‐Enriched Protein Corona on Epigenetic Nanocarrier for Enhanced Synthetic Lethal Therapy;Advanced Science;2024-03-14

5. Mitochondrial-mediated apoptosis as a therapeutic target for FNC (2′-deoxy-2′-b-fluoro-4′-azidocytidine)-induced inhibition of Dalton’s lymphoma growth and proliferation;Discover Oncology;2024-01-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3